Table 2 Individual NPSLE manifestations in 72 SLE patients
NPSLE-manifestation | SLICC A model | SLICC B model | ACR model |
|---|---|---|---|
Any NPSLE-manifestation, n (%) | 16 (22%) | 23 (32%) | 44 (61%) |
Cognitive dysfunction, n (%) | 0 (0%) | 5 (7%) | 26 (36%) |
Headache, n (%) | N/A | N/A | 22 (31%) |
Depression, n (%) | 0 (0%) | 1 (1%) | 13 (18%) |
Anxiety disorder, n (%) | N/A | N/A | 12 (17%) |
Autonomic neuropathy, n (%) | 7 (10%) | 8 (11%) | 10 (14%) |
Cranial neuropathy, n (%) | 7 (10%) | 7 (10%) | 7 (10%) |
Cerebrovascular disease, n (%) | 1 (1%) | 5 (7%) | 5 (7%) |
Demyelinating disease, n (%) | 3 (4%) | 3 (4%) | 3 (4%) |
Myelopathy, n (%) | 2 (3%) | 3 (4%) | 3 (4%) |
Acute confusional state, n (%) | 1 (1%) | 2 (3%) | 3 (4%) |
Polyneuropathy, n (%) | 1 (1%) | 1 (1%) | 3 (4%) |
Seizures, n (%) | 1 (1%) | 2 (3%) | 2 (3%) |
Mononeuritis, n (%) | 1 (1%) | 2 (3%) | 2 (3%) |
Aseptic meningitis, n (%) | 1 (1%) | 1 (1%) | 1 (1%) |
Psychosis, n (%) | 1 (1%) | 1 (1%) | 1 (1%) |
Chorea, n (%) | 0 (0%) | 1 (1%) | 1 (1%) |
Guillain-Barré syndrome, n (%) | 0 (0%) | 0 (0%) | 0 (0%) |
Plexopathy, n (%) | 0 (0%) | 0 (0%) | 0 (0%) |
Myasthenia gravis, n (%) | 0 (0%) | 0 (0%) | 0 (0%) |